These highlights do not include all the information needed to use ACIPHEX DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for ACIPHEX DELAYED-RELEASE TABLETS .
A CIPHEX ® (rabeprazole sodium) d elayed - r elease t ablets , for oral use
Initial U.S. Approval: 1999
RECENT MAJOR CHANGES
Contraindications (4) 04/2016
INDICATIONS AND USAGE
ACIPHEX delayed-release tablets is a proton-pump inhibitor (PPI) indicated in adults for:
-
Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) (1.1).
-
Maintenance of Healing of Erosive or Ulcerative GERD (1.2).
-
Treatment of Symptomatic GERD (1.3).
-
Healing of Duodenal Ulcers (1.4).
-
Helicobacter pylori Eradication to Reduce Risk of Duodenal Ulcer Recurrence (1.5).
-
Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome (1.6).
In adolescent patients 12 years of age and older for:
-
Short-term Treatment of Symptomatic GERD (1.7).
DOSAGE AND ADMINISTRATION
|
Indication |
Recommended Dosage (2) |
|
Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) |
20 mg once daily for 4 to 8 weeks |
|
Maintenance of Healing of Erosive or Ulcerative GERD *studied for 12 months |
20 mg once daily* |
|
Symptomatic GERD in Adults |
20 mg once daily for 4 weeks |
|
Healing of Duodenal Ulcers |
20 mg once daily after morning meal for up to 4 weeks |
|
Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence |
Three Drug Regimen:
ACIPHEX 20 mg
Amoxicillin 1000 mg
|
| 以下是“全球医药”详细资料 |
|
|
